Research and Development
Our solutions span the entire range of drug development, from basic research at the cellular and molecular level to human clinical trials of potential medicines that prevent and cure disease.
Our domain experts leverage the capabilities of our virtual pharmaceutical company, Dynport Vaccine Corporation (DVC) to provide our clients with strategies that reduce management overhead, augment research capabilities and drive cost saving results.
Solutions in the area of Strategy and Process Innovation include:
• In-Licensing: strategies and technologies to rapidly find superior and appropriate in-licensing opportunities that can increase novel therapeutics in an R&D organization’s pipeline.
• Adaptive Trials Strategy: leverages new and emerging techniques for accelerated drug development, improved decision making, and reduced execution time and late phase attrition.
• Bioinformatics Outsourcing: strategies and services for outsourcing key R&D capabilities designed to capture, manage and analyze clinical data.
• Phase I Outsourcing: leverages our deep knowledge of drug development, systems integration, CRO relationship management through a virtual pharmaceutical model
•Clinical Data Management: offers tools to improve and standardize structured data management, and reduce cycle time to submission-readiness.
• Anti-Counterfeiting Strategy: helps to effectively detect counterfeit products, increase audit compliance, enhance supply chain management capabilities and eliminate routing leakage.
Download our white paper on Next Generation R&D (PDF 668KB)
Download our white paper on e-Clinical Avatars and Personalized Medicine Disease Networks
Download our paper on In-Licensing: "Accelerating Competitive Velocity Through Licensing Innovations and Semantic Intelligence" (PDF 494KB)
Click here for more Insights.
For more information, please contact us.